ClassID:

109148

C12N2310/151 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Type of nucleic acid; Nucleic acids forming more than 2 strands, e.g. TFOs more than 3 strands, e.g. tetrads, H-DNA

Recent Application in this class:
#1
20250122496
2025-04-17

TETRAMOLECULAR PARALLEL G-QUADRUPLEX-FORMING HYDROPHOBICALLY MODIFIED OLIGONUCLEOTIDES

#2
20240294919
2024-09-05

Modulating Human Tyrosine Hydroxylase Expression Through Control of Specific G-Quadruplex Formation

#3
20240141002
2024-05-02

SYSTEMS, METHODS, AND COMPOUNDS FOR PROVIDING CHAPERONE ACTIVITY TO PROTEINS

#4
20240052347
2024-02-15

COMPLEX FOR TREATING OPTIC NERVE DISEASE, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#5
20220168429
2022-06-02

NUCLEIC ACID MAZZOCCHIO AND METHODS OF MAKING AND USE THEREOF

#6
20210403983
2021-12-30

COMPOSITIONS AND METHODS FOR DETECTING VIRAL NUCLEIC ACIDS

#7
20210147843
2021-05-20

Systems, methods, and compounds for providing chaperone activity to proteins

#8
20200181607
2020-06-11

TETRAMOLECULAR PARALLEL G-QUADRUPLEX-FORMING HYDROPHOBICALLY MODIFIED OLIGONUCLEOTIDES

#9
20180371526
2018-12-27

COMPOSITIONS AND METHODS FOR DETECTING VIRAL NUCLEIC ACIDS

#10
20170275630
2017-09-28

Aptamer capable of binding to HGF receptor

#11
20170175121
2017-06-22

SELF ASSEMBLING NUCLEIC ACID NANOSTRUCTURES

#12
20170067057
2017-03-09

Compositions and methods for treating cancer, inhibiting cell proliferation, and inducing cell death

#13
20170002355
2017-01-05

cGAP-PNA MULTIVALENT PEPTIDE NUCLEIC ACID LIGAND DISPLAY

#14
20160281090
2016-09-29

MODIFIED DNA QUADRUPLEX-FORMING OLIGONUCLEOTIDES AND METHODS OF USE

#15
20160272977
2016-09-22

DNMT inhibitors

#16
20160194641
2016-07-07

G-rich isoDNA sequences forming G-quadruplex structure, their function as aptamers and a process for the preparation thereof

#17
20160146772
2016-05-26

Fluorescence sensor for target analysis, kit for target analysis, and target analysis method using same

#18
20150240238
2015-08-27

THERAPEUTIC RNA SWITCHES COMPOSITIONS AND METHODS OF USE

#19
20130281518
2013-10-24

Method of reducing inflammatory infiltration in subjects with inflammatory lung disease

#20
20120015874
2012-01-19

NOVEL INHIBITORS OF RETROVIRAL REVERSE TRANSCRIPTACE

#21
20120009170
2012-01-12

Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides

#22
20110218334
2011-09-08

PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS

#23
20110196021
2011-08-11

High Affinity Nucleic Acid Ligands of Complement System Proteins

#24
20110124715
2011-05-26

Antiviral Oligonucleotides Having a Conserved G4 Core Sequence

#25
20090326047
2009-12-31

Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin

#26
20090305281
2009-12-10

Inhibitors of retroviral reverse transcriptase

#27
20090131352
2009-05-21

Aptamers comprising arabinose modified nucleotides

#28
20090082288
2009-03-26

Methods and compositions for the treatment of uveitis

#29
20090075928
2009-03-19

G-quartet oligonucleotides that target hypoxia-inducible factor 1-α (HIF1α)

#30
20080096838
2008-04-24

Guanosine rich oligonucleotides and methods of inducing apoptosis in tumor cells

#31
20070270363
2007-11-22

Modulation of telomere length by oligonucleotides having a G-core sequence

#32
20070015723
2007-01-18

Antiviral oligonucleotides having a conserved G4 core sequence

#33
20060079477
2006-04-13

High affinity nucleic acid ligands of complement system proteins

#34
20050176940
2005-08-11

Aptamers and antiaptamers